READ SIMON (Chief Scientific Officer) sold 61.6% of their position (10K shares) of RA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $470.8K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/18/2019ACC: 0001104659-19-073911
Officer· Chief Scientific Officer
Since Feb 2019
-10K
Net shares
Net seller
$470.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions2
COMMON STOCK
Direct
Shares
+10K
Price / share
$2.87
Trade value
$28.70K
% of position
160.4%
12/17/2019
6.23K→16.23K
COMMON STOCK
Direct
Shares
−10K
Price / share
$47.08
Trade value
$470.82K
% of position
61.6%
12/17/2019
16.23K→6.23K
Total
Net shares
+0.00
Net value
-$442.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK Direct | 12/17/2019 | M · Option Exercise | +10K | $2.87 | $28.70K | 160.4% | 6.23K | 16.23K |
| COMMON STOCK Direct | 12/17/2019 | S · Sale | −10K | $47.08 | $470.82K | 61.6% | 16.23K | 6.23K |
| Total | +0.00 | -$442.12K | ||||||
Derivative Transactions1
Stock Options (Right to buy)
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
2.87
Held after
46.14K
Exercisable
—
12/17/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy) Direct | Common Stock10K shares | 12/17/2019 | M · Option Exercise | −10K | 2.87 | — | 46.14K |